We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts.
- Authors
Khamaisi, Mogher; Sayaka Katagiri; Keenan, Hillary; Kyoungmin Park; Yasutaka Maeda; Qian Li; Weier Qi; Thomou, Thomas; Eschuk, Danielle; Tellechea, Ana; Veves, Aris; Chenyu Huang; Orgill, Dennis Paul; Wagers, Amy; King, George L.; Katagiri, Sayaka; Park, Kyoungmin; Maeda, Yasutaka; Li, Qian; Qi, Weier
- Abstract
Abnormal fibroblast function underlies poor wound healing in patients with diabetes; however, the mechanisms that impair wound healing are poorly defined. Here, we evaluated fibroblasts from individuals who had type 1 diabetes (T1D) for 50 years or more (Medalists, n = 26) and from age-matched controls (n = 7). Compared with those from controls, Medalist fibroblasts demonstrated a reduced migration response to insulin, lower VEGF expression, and less phosphorylated AKT (p-AKT), but not p-ERK, activation. Medalist fibroblasts were also functionally less effective at wound closure in nude mice. Activation of the δ isoform of protein kinase C (PKCδ) was increased in postmortem fibroblasts from Medalists, fibroblasts from living T1D subjects, biopsies of active wounds of living T1D subjects, and granulation tissues from mice with streptozotocin-induced diabetes. Diabetes-induced PKCD mRNA expression was related to a 2-fold increase in the mRNA half-life. Pharmacologic inhibition and siRNA-mediated knockdown of PKCδ or expression of a dominant-negative isoform restored insulin signaling of p-AKT and VEGF expression in vitro and improved wound healing in vivo. Additionally, increasing PKCδ expression in control fibroblasts produced the same abnormalities as those seen in Medalist fibroblasts. Our results indicate that persistent PKCδ elevation in fibroblasts from diabetic patients inhibits insulin signaling and function to impair wound healing and suggest PKCδ inhibition as a potential therapy to improve wound healing in diabetic patients.
- Subjects
PROTEIN kinase C; WOUND healing; FIBROBLASTS; PEOPLE with diabetes; MESSENGER RNA; PHYSIOLOGY; ANIMAL experimentation; CELL culture; CELL physiology; CELL motility; GENETIC techniques; INSULIN; TYPE 1 diabetes; MICE; RESEARCH funding; TIME; TRANSFERASES; VASCULAR endothelial growth factors; DIABETIC foot; PROTEIN kinase inhibitors; DISEASE complications; PHARMACODYNAMICS
- Publication
Journal of Clinical Investigation, 2016, Vol 126, Issue 3, p837
- ISSN
0021-9738
- Publication type
journal article
- DOI
10.1172/JCI82788